Director
DIN: 07895852
Satish Kumar is currently associated with 4 companies in various capacities such as Director, Designated Partner and Individual Promoter. They serve as a Director at ROTISH PHARMATECH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07895852.Satish Kumar is currently involved in 3 different roles. Their most recent position is with MIZIG FARMAKO PRIVATE LIMITED as a Director. The first company Satish Kumar was appointed to as a director was ROTISH PHARMATECH PRIVATE LIMITED. Satish Kumar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Satish Kumar is currently associated with 4 companies in various capacities such as Director, Designated Partner and Individual Promoter. They serve as a Director at ROTISH PHARMATECH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07895852.Satish Kumar is currently involved in 3 different roles. Their most recent position is with MIZIG FARMAKO PRIVATE LIMITED as a Director. The first company Satish Kumar was appointed to as a director was ROTISH PHARMATECH PRIVATE LIMITED. Satish Kumar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
6
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (3)
Current LLPs (1)
Past Companies (0)
1y 6m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ROTISH PHARMATECH PRIVATE LIMITED | Director | 20-Feb-2019 |
| MIZIG PRIVATE LIMITED | Individual Promoter | 20-Mar-2021 |
| MIZIG PRIVATE LIMITED | Director | 20-Mar-2021 |
| MIZIG FARMAKO PRIVATE LIMITED | Director | 04-Jan-2022 |
| MIZIG FARMAKO PRIVATE LIMITED | Individual Promoter | 04-Jan-2022 |